CAS 862502-26-9

L-Threonine,N-(1-oxotetradecyl)-L-seryl-L-leucyl-L-asparaginyl-L-prolyl-L-a-glutamyl-L-tryptophyl-L-asparaginyl-L-a-glutamyl- (9CI)

Description:

L-Threonine, N-(1-oxotetradecyl)-L-seryl-L-leucyl-L-asparaginyl-L-prolyl-L-α-glutamyl-L-tryptophyl-L-asparaginyl-L-α-glutamyl (9CI) is a complex peptide compound characterized by its specific sequence of amino acids, which includes L-threonine, L-serine, L-leucine, L-asparagine, L-proline, L-α-glutamic acid, and L-tryptophan. The presence of a long-chain fatty acid derivative (1-oxotetradecyl) suggests that this compound may exhibit amphiphilic properties, potentially influencing its solubility and interaction with biological membranes. The peptide structure indicates that it may participate in various biological functions, including signaling pathways or serving as a building block for larger proteins. Its CAS number, 862502-26-9, allows for precise identification in chemical databases. As a synthetic or modified peptide, it may have applications in research, pharmaceuticals, or biotechnology, particularly in studies related to protein interactions or drug development. However, specific biological activities and safety profiles would require further investigation through empirical studies.

Formula: C₆₁H₉₄N₁₂O₁₉

Synonyms:

• PKCβII Peptide Inhibitor I trifluoroacetate salt
• Protein Kinase C Beta II Peptide Inhibitor I trifluoroacetate salt

PKCβII Peptide Inhibitor I trifluoroacetate salt

CAS: 862502-26-9

Formula: C₆₁H₉₄N₁₂O₁₉·xC₂HF₃O₂

Molecular weight: 1299.47 (free base

Ref: 7W-GL3036

PKCβII Peptide Inhibitor I

CAS: 862502-26-9

PKCβII Peptide Inhibitor I, a specific PKCβII inhibitor, exhibits cardioprotective properties in a rat cardiac ischemia/reperfusion injury model and mitigates

Formula: C₆₁H₉₄N₁₂O₁₉

Purity: 98%

Color and Shape: Solid

Molecular weight: 1299.47

Ref: TM-T80070

Pkcβii peptide inhibitor I trifluoroacetate salt

CAS: 862502-26-9

Pkcβii peptide inhibitor I trifluoroacetate salt is a specific peptide inhibitor that targets the protein kinase C beta II (PKCβII) isoform. This inhibitor is commonly sourced from synthetic peptide libraries and is integrated with trifluoroacetate as a counterion to enhance stability and solubility. The mode of action involves the selective inhibition of PKCβII, interfering with its role in cellular signaling pathways. As PKCβII is implicated in the regulation of various cellular processes such as growth, differentiation, and apoptosis, the inhibitor is valuable for elucidating the mechanistic roles of this kinase in cellular physiology and pathophysiology.The Pkcβii peptide inhibitor I trifluoroacetate salt is primarily utilized in biochemical and cellular research to investigate the specific pathways mediated by PKCβII. Its applications extend to studies involving cancer research, diabetes, cardiovascular diseases, and other conditions where PKCβII's activity is a contributing factor. By enabling precise inhibition, researchers can dissect the isoform-specific effects and potentially tailor therapeutic strategies, thus advancing the understanding of PKCβII's function in health and disease.

Formula: C₆₁H₉₄N₁₂O₁₉·C₂HF₃O₂

Purity: (%) Min. 95%

Molecular weight: 1,299.47 g/mol

Ref: 3D-MJB50226